Literature DB >> 7988203

Survival analysis of untreated patients with non-small-cell lung cancer.

E Vrdoljak1, K Mise, D Sapunar, A Rozga, M Marusić.   

Abstract

The survival rate analysis of 130 patients with non-small-cell lung cancer who did not receive any specific anticancer therapy showed no statistically significant differences in the survival rates between various TNM combinations classified into stage groups II, IIIa, IIIb, and IV, as proposed by Mountain in 1989 and adopted by the American Joint Committee on Cancer. Following these findings, based on survival probabilities, two distinctive staging groups could be distinguished. The first stage group was composed of only the T1, 2N0, M0 combination, and the second of all other TNM combinations. In a purely biologic sense of tumor growth, the lymph node involvement appeared to be the crucial factor determining the length of survival.

Entities:  

Mesh：

Year:  1994        PMID： 7988203     DOI： 10.1378/chest.106.6.1797

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


  9 in total

1.  Effect of histologic type on recurrence pattern in radiation therapy for medically inoperable patients with stage I non-small-cell lung cancer.

Authors:  Hitoshi Ishikawa; Yuko Nakayama; Yoshizumi Kitamoto; Tetsuo Nonaka; Hidemasa Kawamura; Katsuyuki Shirai; Hideyuki Sakurai; Kazushige Hayakawa; Hideo Niibe; Takashi Nakano
Journal:  Lung       Date:  2006-11-03       Impact factor: 2.584

2.  Cancer-associated loss of TARSH gene expression in human primary lung cancer.

Authors:  Kunihiko Terauchi; Junichi Shimada; Natsuko Uekawa; Takeshi Yaoi; Mitsuo Maruyama; Shinji Fushiki
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-04       Impact factor: 4.553

Review 3.  Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review.

Authors:  N P Rowell; C J Williams
Journal:  Thorax       Date:  2001-08       Impact factor: 9.139

4.  Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer.

Authors:  Samuel Cykert; Peggye Dilworth-Anderson; Michael H Monroe; Paul Walker; Franklin R McGuire; Giselle Corbie-Smith; Lloyd J Edwards; Audrina Jones Bunton
Journal:  JAMA       Date:  2010-06-16       Impact factor: 56.272

Review 5.  Challenges in the treatment of early non-small cell lung cancer: what is the standard, what are the challenges and what is the future for radiotherapy?

Authors:  Almudena Cascales; Florent Martinetti; Deborah Belemsagha; Cecile Le Pechoux
Journal:  Transl Lung Cancer Res       Date:  2014-08

Review 6.  NSCLC in the elderly--the legacy of therapeutic neglect.

Authors:  Jared Weiss; Corey Langer
Journal:  Curr Treat Options Oncol       Date:  2009-05-16

Review 7.  Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysis.

Authors:  Hesborn Wao; Rahul Mhaskar; Ambuj Kumar; Branko Miladinovic; Benjamin Djulbegovic
Journal:  Syst Rev       Date:  2013-02-04

8.  Safety and efficacy of thoracoscopic wedge resection for elderly high-risk patients with stage I peripheral non-small-cell lung cancer.

Authors:  Ling Lin; Dingzhong Hu; Chenxi Zhong; Heng Zhao
Journal:  J Cardiothorac Surg       Date:  2013-12-21       Impact factor: 1.637

Review 9.  Radiofrequency ablation for early-stage nonsmall cell lung cancer.

Authors:  Takao Hiraki; Hideo Gobara; Toshihiro Iguchi; Hiroyasu Fujiwara; Yusuke Matsui; Susumu Kanazawa
Journal:  Biomed Res Int       Date:  2014-06-03       Impact factor: 3.411
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.